Table 3. The role of the ShET1 and ShET2 enterotoxins.
Strain | Adverse clinical outcomes | IgA anti-O-antigen ASC | ||||||
---|---|---|---|---|---|---|---|---|
Diarrhoea | Dysentery | Fever | % Responders | Geometric Mean* | ||||
108 | 109 | 108 | 109 | 108 | 109 | 109 | N/A | |
ΔguaBA (CVD 1204) | 3/7 (43%) | 4/7 (57%) | 0/7 | 0/7 | 0/7 | 4/7 | 100% | 445 |
ΔguaBA, Δset, Δsen, (CVD 1208) | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 1/7 | 86% | 62 |
This Table shows the consistency of the clinical and immunological response in North American adult volunteers to ingestion of 108 or 109 colony-forming units (CFU) of two deletion mutants of wild-type S. flexneri 2a strain 2457T with NaHCO3 buffer.
Per 106 PBMC. ASC, antibody-secreting cells; PBMC, peripheral blood mononulcear cells; ShET, Shigella enterotoxin.